University of Pennsylvania | Pathology and Laboratory Medicine

FDA Approves Personalized Cellular Therapy for Advanced Leukemia

August 30, 2017

Landmark decision for the field of cancer immunotherapy for first therapy based on gene transfer approved by the FDA.

First Atlas of B-cell Clones in Human Body for Infectious Disease Research

August 29, 2017

Prak Lab publishes “anatomic atlas” of B cells in Nature Biotechnology for research in infectious diseases, microbiome, vaccine responses, and tissue-specific immunity.

New Faculty Members in the Department for the Academic Year 2017-18

August 23, 2017

Specialty expertise in bioinformatics, genomic diagnostics, molecular therapeutics, neurogenetics, immunology, RNA biomarkers, RNA sequencing, clinical cytogenetics, placental pathology, and molecular neuropathology.

Penn-led Study Finds Retention of One Normal Version of BRCA Gene in Breast and Ovarian Cancers Influences Patient Survival

August 22, 2017

Analyses of BRCA1 and BRCA2 germline mutation-associated breast and ovarian tumors determines clinically useful biomarker to predict primary resistance to DNA damaging agents.

2017 CAP Inspection Concludes

August 11, 2017

College of American Pathologists summation report confirms the highest standards in quality, laboratory leadership, and day-to-day laboratory operations for the Department’s major anatomic and clinical pathology divisions.

Award for Dr. Doug Cines for Significant Contributions to Research and Education in Blood Coagulation

August 10, 2017

ISTH BACH Award for his exemplary models of research and mentoring excellence by International Society on Thrombosis and Haemostatis.

Pilot Study Tests CAR T-Cell Immunotherapy in Glioblastomas

July 20, 2017

Science Translational Medicine reports results of phase 1 safety study of autologous CAR T cells targeted to EGFR variant III in glioblastoma patients.

Nature Genetics Study on Rare Gene Variants Implicates Innate Immunity in Alzheimer's Disease

July 17, 2017

Three new coding variants found in genome-wide association study point to the brain’s immune cells in the onset of the disorder.

FDA Approval Recommendation for CAR T-Cell Therapy

July 14, 2017

FDA advisory committee unanimously approves first personalized cellular therapy developed at Penn for pediatric and young adult leukemia.

Department Accomplishments and Achievements Summer 2017

July 07, 2017

Burroughs Wellcome Fund Award for Dr. Vijay Bhoj, 2017 Pew Scholar in Biomedical Sciences for Dr. Jorge Henao-Mejia, Paul Janssen Award for Biomedical Research for Dr. Douglas Wallace, and other honors by Department members.